Search results
Results from the WOW.Com Content Network
Fuchs spots are caused by regression of choroidal neovascularization. [3] Since it is a medical sign, treatment is given for the actual cause. Photothermal laser ablation, photodynamic therapy, anti-VEGF therapy, or a combination of these are the treatment options of choroidal neovascularization due to pathological myopia.
In many cases, myopia will stabilize once the growth process has been completed, but in more severe chronic cases, loss of vision can occur. Degenerative myopia, also known as malignant, pathological, or progressive myopia, is characterized by posterior sclera elongation and thinning (at least 25.5 mm to 26.5 mm) and high refractive errors of ...
Layers of the eye, with the choroid labelled. Choroidal neovascularization (CNV) is the creation of new blood vessels in the choroid layer of the eye.Choroidal neovascularization is a common cause of neovascular degenerative maculopathy (i.e. 'wet' macular degeneration) [1] commonly exacerbated by extreme myopia, malignant myopic degeneration, or age-related developments.
In myopia that is no longer progressing, the crescent may be asymptomatic except for its presence on ocular examination. However, in high-degree myopia, it may extend to the upper and lower borders, or form a complete ring around the optic disc and form a central scotoma. The myopic crescent is commonly seen in pathological axial myopia.
High myopia usually describes myopia of −6.00 or more. [65] [84] People with high myopia are more likely to have retinal detachments [85] and primary open angle glaucoma. [86] They are also more likely to experience floaters, shadow-like shapes which appear in the field of vision. [87]
Conbercept is a soluble receptor decoy that binds specifically to VEGF-B, placental growth factor (PlGF), and various isoforms of VEGF-A. [1] [4] [15] Conbercept has a VEGF-R2 kinase insert domain receptor (KDR) Ig-like region 4 (KDRd4) which improves the three-dimensional structure and efficiency of dimer formation, thereby increasing the binding capacity of conbercept to VEGF.
He has designed surgical instruments and holds several patents related to imaging technologies and treatments for retinal diseases. [17] [18] [19] [10] Dr. Spaide is affiliated with Vitreous Retina Macula Consultants of New York, where he continues his research and clinical work. [6] [3] [20] [9]
Dilated fundus examination (DFE) is a diagnostic procedure that uses mydriatic eye drops to dilate or enlarge the pupil in order to obtain a better view of the fundus of the eye. [1] Once the pupil is dilated, examiners use ophthalmoscopy to view the eye's interior, which makes it easier to assess the retina , optic nerve head , blood vessels ...